Dr. Krista Vandenborne and Claudia Senesac, PT, PhD, PCS, both from the University of Florida, discuss the ImagingDMD Study. This study focuses on developing Magnetic Resonance Imaging (MRI) as a tool to monitor disease progression in Duchenne and to serve as an outcome measure for clinical trials.
The aim of the study is to determine whether noninvasive MRI outcome measures can replace muscle biopsies in evaluating the effectiveness of new treatments in future clinical trials. A second goal of this study is to characterize the progressive involvement of the lower extremity muscles to help guide the design of future clinical trials.
The ImagingDMD Study has three sites in the US: University of Florida in Gainesville, FL; The Children's Hospital of Philadelphia in Philadelphia, PA; and Oregon Health and Science University in Portland, OR. To learn more, visit their website at www.imagingdmd.org.